Triple-negative breast cancer (TNBC) is immunohistochemically defined as estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and human epidermal growth factor receptor 2 (HER2) nonamplified breast cancer. Here, ESR1 is linked to triple-negative breast carcinoma.